These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

164 related items for PubMed ID: 752907

  • 21. Oscillations in performance in levodopa-treated parkinsonians: treatment with bromocriptine and L-deprenyl.
    Lander CM, Lees A, Stern G.
    Clin Exp Neurol; 1979; 16():197-203. PubMed ID: 121706
    [Abstract] [Full Text] [Related]

  • 22. Hypersexuality--a complication of dopaminergic therapy in Parkinson's disease.
    Vogel HP, Schiffter R.
    Pharmacopsychiatria; 1983 Jul; 16(4):107-10. PubMed ID: 6685318
    [Abstract] [Full Text] [Related]

  • 23. Bromocriptine and lisuride in Parkinson disease.
    Lieberman AN, Gopinathan G, Neophytides A, Leibowitz M, Walker R, Hiesiger E.
    Ann Neurol; 1983 Jan; 13(1):44-7. PubMed ID: 6830164
    [Abstract] [Full Text] [Related]

  • 24. [CB 154 in the treatment of Parkinson's disease. Results in combination with L-dopa and decarboxylase inhibitor].
    Meco G, Casacchia M, Zamponi A, Agnoli A.
    Acta Neurol (Napoli); 1976 Jan; 31(4):479-48. PubMed ID: 1037427
    [No Abstract] [Full Text] [Related]

  • 25. [Improved therapeutic response to L-dopa in Parkinson's disease, when combined with bromocriptine (author's transl)].
    Ulm G.
    Nervenarzt; 1981 Feb; 52(2):116-20. PubMed ID: 7219619
    [No Abstract] [Full Text] [Related]

  • 26. Early combination of bromocriptine and levodopa in Parkinson's disease: a prospective randomized study of two parallel groups over a total follow-up period of 44 months including an initial 8-month double-blind stage.
    Giménez-Roldán S, Tolosa E, Burguera JA, Chacón J, Liaño H, Forcadell F.
    Clin Neuropharmacol; 1997 Feb; 20(1):67-76. PubMed ID: 9037575
    [Abstract] [Full Text] [Related]

  • 27. [L-dopa and bromocriptine in Parkinson disease. Early combination therapy has better effect].
    Olsson JE, Duchek M, Ekberg R, Fehling C, Johansson F, Johnels B, Lindvall B, Nordin G, Sidén A, Steg G.
    Lakartidningen; 1993 Apr 21; 90(16):1545-8. PubMed ID: 8483351
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Quantitative description of loss of clinical benefit following withdrawal of levodopa-carbidopa and bromocriptine in early Parkinson's disease.
    Hauser RA, Holford NH.
    Mov Disord; 2002 Sep 21; 17(5):961-8. PubMed ID: 12360545
    [Abstract] [Full Text] [Related]

  • 33. [Treatment of Parkinson's disease with the combination drug L-carbidopa/L-dopa. Report on a 2 years study].
    Hayek J.
    Schweiz Med Wochenschr; 1977 Apr 09; 107(14):474-9. PubMed ID: 847450
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. [Treatment of parkinsonian syndromes by bromocriptin].
    Gautier JC, Durand JP.
    Nouv Presse Med; 1977 Jan 22; 6(3):171-4. PubMed ID: 319421
    [Abstract] [Full Text] [Related]

  • 36. Treatment of Parkinson's disease: levodopa as the first choice.
    Katzenschlager R, Lees AJ.
    J Neurol; 2002 Sep 22; 249 Suppl 2():II19-24. PubMed ID: 12375059
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. [5 years of experience in the treatment of parkinsonism with L-dopa and its combination with Ro4-4602].
    Romero S, Chouza C, Gomensoro JB.
    Neurol Neurocir Psiquiatr; 1976 Sep 22; 17(4):239-54. PubMed ID: 1018727
    [Abstract] [Full Text] [Related]

  • 39. [Development of studies on the treatment of parkinsonian syndromes with levodopa. II. Long-term effects of L-DOPA alone or in combination with a decarboxylase inhibitor].
    Rabadeau Dumas JL, Rondot P, Cardon P.
    Therapie; 1977 Sep 22; 32(2):161-72. PubMed ID: 898124
    [No Abstract] [Full Text] [Related]

  • 40. Bromocriptine and levodopa (with or without carbidopa) in parkinsonism.
    Kartzinel R, TEYCHENNE P, Gillespie MM, Perlow M, Gielen AC, Sadowsky DA, Calne DB.
    Lancet; 1976 Aug 07; 2(7980):272-5. PubMed ID: 59850
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.